The technological world of the Northern Netherlands is once again buzzing with energy now that one of the leading members of the ICD innovation cluster, the Photonis Group, has undergone a major transformation. Since September 20, 2023, the company will continue under the name Exosens, marking a new phase in their ambition to become the world leader in detection and imaging technologies.
The choice of Exosens is not just a name change; it symbolizes the broad horizon that the company envisions. With a focus on sectors such as life sciences, industrial control, nuclear energy and defense, Exosens is committed to creating a safer and more efficient world with its advanced technologies.
Within these domains, Exosens offers a wide range of solutions, ranging from electro-optical devices to advanced electron, ion, neutron and gamma detectors. These technologies have the potential to revolutionize many industries, including improved healthcare diagnostics, more accurate industrial controls, and strong support for nuclear energy initiatives.
The recent acquisitions of companies such as Xenics, Proxivision, Telops and Elmul demonstrate the growing reach of Exosens. With more than 1,500 dedicated employees and manufacturing and R&D facilities in nine locations across Europe and North America, the company is firmly positioned to make a lasting mark on the high-tech industry.
As a member of the ICD in the Northern Netherlands, Exosens is on the front line of technological innovation. With more than 85 years of experience in the field, the company's recent transformation demonstrates their continued commitment to progress and their commitment to providing solutions to some of the most pressing challenges of our time.
ALSO VIEW THE VIDEO
For more information about Exosens and their innovative solutions, please visit them official website or contact it ICD for further details about the high-tech ecosystem of the Northern Netherlands.